These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9848892)

  • 1. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.
    George J; Afek A; Gilburd B; Levkovitz H; Shaish A; Goldberg I; Kopolovic Y; Wick G; Shoenfeld Y; Harats D
    Atherosclerosis; 1998 May; 138(1):147-52. PubMed ID: 9678780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
    Palinski W; Miller E; Witztum JL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.
    Zhou X; Caligiuri G; Hamsten A; Lefvert AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):108-14. PubMed ID: 11145941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.
    Sun J; Hartvigsen K; Chou MY; Zhang Y; Sukhova GK; Zhang J; Lopez-Ilasaca M; Diehl CJ; Yakov N; Harats D; George J; Witztum JL; Libby P; Ploegh H; Shi GP
    Circulation; 2010 Aug; 122(8):808-20. PubMed ID: 20697023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
    Binder CJ; Hartvigsen K; Chang MK; Miller M; Broide D; Palinski W; Curtiss LK; Corr M; Witztum JL
    J Clin Invest; 2004 Aug; 114(3):427-37. PubMed ID: 15286809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
    Kummu O; Turunen SP; Wang C; Lehtimäki J; Veneskoski M; Kastarinen H; Koivula MK; Risteli J; Kesäniemi YA; Hörkkö S
    Antioxid Redox Signal; 2013 Oct; 19(10):1047-62. PubMed ID: 23311771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
    Palinski W; Tangirala RK; Miller E; Young SG; Witztum JL
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1569-76. PubMed ID: 7583529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP; Zhou X
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
    Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
    PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    Zhou X; Paulsson G; Stemme S; Hansson GK
    J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
    Pedersen TX; Binder CJ; Fredrikson GN; Nilsson J; Bro S; Nielsen LB
    Nephrol Dial Transplant; 2010 Aug; 25(8):2486-91. PubMed ID: 20164045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
    Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.
    Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S
    Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits.
    Ameli S; Hultgårdh-Nilsson A; Regnström J; Calara F; Yano J; Cercek B; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1074-9. PubMed ID: 8696949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.